Advertisement

Topics

Prostate Oncology Specialists,Inc. Company Profile

05:38 EST 14th December 2018 | BioPortfolio

Prostate Oncology Specialists is a medical group exclusively devoted to caring for men with prostate cancer. We have vast experience diagnosing and treating prostate cancer because 100% of our time is focused on managing men with this disease. Our physicians are board certified in both medical oncology and internal medicine and have made significant contributions to the scientific advancement in this field

Location

4676 Admiralty Way, Suite 101
Marina del Rey
California
90292
United States of America

Contact

Phone: 310.827.7707
Fax: 310.574.4002
Email: linda@prostateoncology.com


News Articles [1438 Associated News Articles listed on BioPortfolio]

GU/Prostate Cancer | Medscape

Review in-depth clinical information, latest medical news, and guidelines on prostate cancer and prostate cancer treatment including prostate cancer surgery. Learn about prostate cancer prognosis for ...

Inflammatory Bowel Disease Linked to Prostate Cancer

NewsMen with inflamed guts are four to five times at risk for prostate cancer.Contributed Author: 

Which Approach is Best for Biopsy Gleason Score 9–10 Prostate Cancer?

A recent study in JAMA Oncology compared survival for various multi-modality approaches for treating aggressive prostate cancer.

Prostate cancer researchers win $2m to explore carboplatin therapy

The US Department of Defence has awarded a coalition of researchers – made up of the Prostate Cancer Clinical Research Unit of the Spanish National Cancer Research Center (CNIO), the Prostate Cancer...

Clovis Oncology shares pop after prostate cancer drug Rubraca gets 'breakthrough therapy' designation

The review of Rubraca by the FDA for the treatment of BRCA ½ mutated metastatic castration-resistant prostate cancer will be expedited

Hypofractionated Radiation OK for Localized Prostate CA

MONDAY, Oct. 29, 2018 -- A new clinical guideline for early-stage prostate cancer supports the use of shortened courses of radiation therapy, according to an article published in Practical Radiation O...

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

What you need to knowPSA testing has increased the number of men diagnosed with and treated for prostate cancer, but many of these men would never have experienced any symptoms or death from prostate....

Curing More Prostate Cancer: Thinking Through the Options

Clinical trials in prostate cancer often take years or decades to yield results. Can time to results be lessened? Journal of Clinical Oncology

PubMed Articles [2454 Associated PubMed Articles listed on BioPortfolio]

Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of a non-aggressive disease.

Management of localized prostate cancer is a major clinical challenge since most of these cancers won't evolve but a majority of patients will still undergo a life-changing radical surgery. Molecular ...

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches.

Prostate Cancer is the forth most common type of cancer. Prostate-specific membrane antigen (PSMA) is anchored in the cell membrane of prostate epithelial cells. PSMA is highly expressed on prostate e...

Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.

Quality indicators (QIs) have been developed for many aspects of prostate cancer care, but are under-developed with regard to radiotherapy treatment. We aimed to develop a valid, relevant and feasible...

Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology.

The knowledge in the field of castration-resistant prostate cancer (CRPC) is developing rapidly, with emerging new therapies and advances in imaging. Nonetheless, in multiple areas there is still a la...

Patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer.

There is considerable interest in very short (ultrahypofractionated) radiotherapy regimens to treat prostate cancer based on potential radiobiological advantages, patient convenience and resource allo...

Clinical Trials [3176 Associated Clinical Trials listed on BioPortfolio]

Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring

The SPARK trial is testing the use of Kilovoltage Intrafraction Monitoring in prostate cancer patients being treated with Stereotactic Prostate Adaptive Radiotherapy. The researchers expe...

Collection of Blood From Patients With Prostate Cancer

Background: - It is not fully understood why prostate cancer in some men becomes androgen-independent (no longer responds to anti-androgen medication), but genetics likely plays a...

PALLiON - PALLiative Care In ONcology

A major concern in today's oncology is the complexity of treatment that increases costs. A main contributor is the increasing use of chemo- and radiotherapy during end of life (EoL: the la...

Hypofractionated SBRT For Prostate Cancer

The purpose of this study is to determine, in both low-risk and intermediate-risk cohorts, the rates of acute and late grade 3 or higher gastrointestinal and genitourinary toxicity observe...

Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies

Prostate cancer is the first cancer in humans (25%). The most widely used tracer in oncology, the 18-Fluoro DeoxyGlucose does not allow the study of prostatic neoplasia. On the other hand,...

Companies [1371 Associated Companies listed on BioPortfolio]

Prostate Oncology Specialists,Inc.

Prostate Oncology Specialists is a medical group exclusively devoted to caring for men with prostate cancer. We have vast experience diagnosing and treating prostate cancer because 100% of our time is...

Prostate Oncology Specialists, Inc.

According to the American Cancer Society, prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than two million men in the United St...

Texas Oncology

Texas Oncology delivers high-quality cancer care with leading-edge technology and advanced treatment and therapy options available to help patients achieve “More breakthrough...

Minomic International Ltd

Minomic International Ltd is an Australian immuno-oncology company specialising in therapeutics and diagnostics for prostate cancer and other cancers. Minomic has developed the in...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

More Information about "Prostate Oncology Specialists,Inc." on BioPortfolio

We have published hundreds of Prostate Oncology Specialists,Inc. news stories on BioPortfolio along with dozens of Prostate Oncology Specialists,Inc. Clinical Trials and PubMed Articles about Prostate Oncology Specialists,Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prostate Oncology Specialists,Inc. Companies in our database. You can also find out about relevant Prostate Oncology Specialists,Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record